Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
08/06/202014h00PR Newswire (US)Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF...NASDAQ:INSMInsmed Inc
05/06/202014h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
26/05/202014h00PR Newswire (US)Insmed to Present at Two June ConferencesNASDAQ:INSMInsmed Inc
21/05/202022h10Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:INSMInsmed Inc
21/05/202022h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
20/05/202015h29PR Newswire (US)Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials SessionNASDAQ:INSMInsmed Inc
14/05/202022h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
05/05/202023h30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INSMInsmed Inc
05/05/202014h00PR Newswire (US)Insmed Announces Pricing of Public Offering of Common StockNASDAQ:INSMInsmed Inc
04/05/202022h01PR Newswire (US)Insmed Announces Proposed Public Offering of Common StockNASDAQ:INSMInsmed Inc
30/04/202013h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
30/04/202013h30PR Newswire (US)Insmed Reports First Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/04/202012h00PR Newswire (US)Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated TrialNASDAQ:INSMInsmed Inc
20/04/202014h00PR Newswire (US)Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020NASDAQ:INSMInsmed Inc
02/04/202023h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
02/04/202023h46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
02/04/202014h00PR Newswire (US)Insmed Appoints Carol A. Schafer to its Board of DirectorsNASDAQ:INSMInsmed Inc
31/03/202015h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
31/03/202015h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
27/03/202023h39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:INSMInsmed Inc
16/03/202022h36Dow Jones NewsInsmed: AstraZeneca Exercises Exclusive Option to Advance INS1007NASDAQ:INSMInsmed Inc
16/03/202021h01PR Newswire (US)Insmed Provides Business UpdateNASDAQ:INSMInsmed Inc
04/03/202014h00PR Newswire (US)Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amik...NASDAQ:INSMInsmed Inc
26/02/202014h00PR Newswire (US)Insmed to Present at the Cowen and Company 40th Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
25/02/202013h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
25/02/202013h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
19/02/202014h00PR Newswire (US)Insmed to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
14/02/202020h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
10/02/202014h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, February 25, 2020NASDAQ:INSMInsmed Inc
03/02/202013h30PR Newswire (US)Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchie...NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM